Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 463

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 463
---
 ​ |
| Net Change in Cash                                                                   | ​ | ​ | ​            | ​ |    -124,215 | ​ | ​ | ​ | ​    | ​ |      -55,588 | ​ | ​ |
| Cash, beginning of year                                                              | ​ | ​ | ​            | ​ |     280,640 | ​ | ​ | ​ | ​    | ​ |      336,228 | ​ | ​ |
| Cash, end of year                                                                    | ​ | ​ | ​            | $ |     156,425 | ​ | ​ | ​ | ​    | $ |      280,640 | ​ | ​ |
| Supplemental disclosure of cash and non-cash operating and financing activities:     | ​ | ​ | ​            | ​ |           ​ | ​ | ​ | ​ | ​    | ​ |            ​ | ​ | ​ |
| Income taxes paid                                                                    | ​ | ​ | ​            | $ |     193,845 | ​ | ​ | ​ | ​    | $ |            — | ​ | ​ |
| Excise tax payable                                                                   | ​ | ​ | ​            | $ |     103,587 | ​ | ​ | ​ | ​    | $ |            — | ​ | ​ |
| Conversion of Class B common stock to Class A common stock                           | ​ | ​ | ​            | $ |         690 | ​ | ​ | ​ | ​    | $ |            — | ​ | ​ |
| Remeasurement of Class A common stock subject to redemption value                    | ​ | ​ | ​            | $ |     420,786 | ​ | ​ | ​ | ​    | $ |    3,091,534 | ​ | ​ |
| Derivative on promissory note – related party                                        | ​ | ​ | ​            | ​ |     104,428 | ​ | ​ | ​ | ​    | ​ |            — | ​ | ​ |
| Forgiveness of payable due to an affiliate of the Sponsor                            | ​ | ​ | ​            | $ |           — | ​ | ​ | ​ | ​    | $ |      140,000 | ​ | ​ |

The accompanying notes are an integral part of these financial statements. F-32

TABLE OF CONTENTS

### IRIS ACQUISITION CORP

### NOTES TO FINANCIAL STATEMENTS

### NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Iris Acquisition